A combined approach on the impact of EP300 overexpression on drug resistance, invasion and stemness in breast cancer

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.